[1]张柏钰,张广德,韩淑花.张广德从温病少阳证辨治亚急性甲状腺炎经验[J].陕西中医,2021,(6):776-779.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.026]
　ZHANG Baiyu,ZHANG Guangde,HAN Shuhua.Zhang Guangde's experience in treating subacute thyroiditis from Wenbing Shaoyang syndrome[J].,2021,(6):776-779.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.026]
点击复制

张广德从温病少阳证辨治亚急性甲状腺炎经验
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年6期
页码:
776-779
栏目:
名中医经验
出版日期:
2021-06-05

文章信息/Info

Title:
Zhang Guangde's experience in treating subacute thyroiditis from Wenbing Shaoyang syndrome
作者:
张柏钰1; 2; 张广德2; 韩淑花2
(1.中国中医科学院,北京 100700; 2.中国中医科学院西苑医院,北京 100091)
Author(s):
ZHANG Baiyu; ZHANG Guangde; HAN Shuhua
(China Academy of Chinese Medical Sciences,Beijing 100700,China)
关键词:
亚急性甲状腺炎;  温病;  瘿病;  少阳证;  和解少阳;  清热解毒
Keywords:
Subacute thyroiditis;  Wenbing;  Yingbing;  Shaoyang syndrome;  Hejie Shaoyang;  Qingre Jiedu
分类号:
R 581
DOI:
DOI:10.3969/j.issn.1000-7369.2020.06.026
文献标志码:
A
摘要:
亚急性甲状腺炎(SAT)是一种以甲状腺肿大、疼痛伴发热为主要临床表现的甲状腺炎症疾病,针对SAT轻症患者,西医主要采用非甾体类抗炎药,严重者则合并使用糖皮质激素。西医治疗该病存在停药易反复、疗程长、不良反应多等问题。根据SAT临床表现,将其归属于中医“瘿病”范畴,中医药治疗SAT具有疗程短、疗效较好、不良反应少等优势。张广德教授认为SAT主要病因是外感温毒时邪伴情志失调,发病机制为少阳枢机不利,肝胆疏泄失常,气滞血凝痰结,主张从温病少阳证论治本病,以和解少阳、清热解毒为治疗大法,辅以疏泄肝胆、行气活血、化痰散结消痈药物,后期则注意顾护正气。
Abstract:
Subacute thyroiditis(SAT)is an inflammatory disease of the thyroid with goiter,pain and fever as main clinical manifestations.Western medicine mainly uses non-steroidal anti-inflammatory drugs in patients with mild SAT symptoms,and glucocorticoids in severe patients.Western medicine treatment is easy to stop repeatedly,long course of treatment,many adverse reactions and other problems.According to the clinical manifestations of SAT, it belongs to Yingbing of traditional Chinese medicine.Traditional Chinese medicine has the advantages of short course of treatment,good curative effect and less adverse reactions.Professor Zhang Guangde believes that the main cause of SAT is Wendu Shixie companion emotional disorder.The pathogenesis of SAT is that Shaoyang Shuji Buli,Gandan Shuxie abnormal,Qizhi Xueyu Tanjie.He treats the disease from Shaoyang syndrome of Wenbing,taking reconciliation of Shaoyang,Qingre Jiedu as the main treatment,supplemented by drugs for Shuxie Gandan,Xingqi Huoxue,Huatan Sanjie,Xiaoyong,and paying attention to Zhengqi in the later stage.

参考文献/References:

[1] Fatourechi V,Aniszewki JP,Fatourechi GZ,et al.Clinical features and outcome of subacute thyroiditis in an incidence cohort:Olmsted county,minnesota,study[J].J Clin Endocrinol Metab,2013,88(5):2100-2105.
[2] 胡 茗,钱 敏,王一峰,等.血清T3/T4在亚急性甲状腺炎与Graves'病鉴别诊断中的价值[J].陕西医学杂志,2019,48(6):807-809.
[3] 刘艳骄,魏军平,杨洪军.甲状腺疾病中西医结合治疗学[M].北京:科学技术文献出版社,2012:223.
[4] 王小玲,吕合作,甘怀勇,等.Treg在亚急性甲状腺炎发病免疫机制中的作用[J].基础医学与临床,2018,38(2):218-223.
[5] 朱昱霖,徐海波,宰国田.亚急性甲状腺炎激素治疗进展[J].中国临床研究,2020,33(12):1720-1722.
[6] Li F,Wu Y,Chen L,et al.Initial treatment combined with prunellavulgaris reduced prednisolone consumption for patients with subacutethyroiditis[J].Ann Transl Med,2019,7(3):45.
[7] 田淋蓥,和 欢,曹 洁,等.中西医结合治疗亚急性甲状腺炎(肝火痰瘀证)的临床观察[J].中国中医急症,2021,30(1):113-116.
[8] 杨晓琴,刘香春.普济消毒饮联合泼尼松治疗亚急性甲状腺炎疗效及对血清TRAb及TPOAb水平的影响[J].新中医,2021,53(2):25-28.
[9] 王 娟,柳正清,张梅香,等.化浊解毒方治疗亚急性甲状腺炎的疗效研究[J].中国中医急症,2021,30(2):274-277.
[10] 李 游,尹 婷,尤 亚.少阳病提纲证的病机及治疗探析[J].中华中医药志,2015,30(10):3429-3432
[11] 郝永龙,陈美荣,刘向红.基于象思维认识中药药性理论[J].中华中医杂志,2020,35(3):1230-1232.
[12] 于 亮,王 芳,郭 琪,等.白花蛇舌草的化学成分及其药理活性研究进展[J].沈阳药科大学学报,2017,34(12):1104-1114.
[13] 李翎熙,陈迪路,周小江.玄参化学成分、药理活性研究进展及其质量标志物分析预测[J].中成药,2020,42(9):2417-2426.
[14] 徐多多.玄参大鼠体内代谢成分分析及其对醛糖还原酶抑制活性研究[D].北京:北京中医药大学,2016.
[15] 淑 英,陈 秋.亚急性甲状腺炎中医辨证治疗的研究总结与体会[J].世界最新医学信息文摘,2019,19(99):268-269.
[16] 杨 杰,苗桂珍,缪 娟,等.基于六经理论探讨亚急性甲状腺炎的传变规律及防治[J].中华中医药杂志,2020,35(12):5960-5963.
[17] 李会敏,杨哲昀,谢 敏,等.左新河分期论治亚急性甲状腺炎经验[J].湖北中医杂志,2020,42(10):23-26.
[18] 李 品,臧凝子,李小娟,等.亚急性甲状腺炎中西医研究进展[J].辽宁中医药大学学报,2020,22(5):126-129.
[19] 李淑玲,冯建明.太子参及其伪品白花紫萼女蒌菜根的鉴别[J].陕西中医,2010,31(1):103-104.
[20] 王美子,杨宇峰,石 岩.中医瘿病的古文献研究[J].江苏中医药,2018,50(12):74-77.

相似文献/References:

[1]黄 飞,张 雪,张亚强,等.从桂林古本《伤寒论》阐释新型冠状病毒肺炎的辨证认知[J].陕西中医,2020,(6):703.[doi:DOI:10.3969/j.issn.10007369.2020.06.002]
[2]王立石,石 鹏,黄黎明.六经辨证在新型冠状病毒肺炎诊治中的应用[J].陕西中医,2021,(6):767.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.023]
　WANG Lishi,SHI Peng,HUANG Liming.Application of Liujing Bianzheng in diagnosis and treatment of COVID-19[J].,2021,(6):767.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.023]
[3]王恒鑫,刘桂余,郭振兴,等.透邪法在治疗湿热型脾胃病中的应用[J].陕西中医,2021,(8):1108.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.030]
　WANG Hengxin,LIU Guiyu,GUO Zhenxing,et al.Application of permeating pathogens method in treating spleen and stomach disease of damp heat type[J].,2021,(6):1108.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.030]
[4]钱琳琳,张美伦,马晓北.《温病条辨》中温热类病证用药规律探究[J].陕西中医,2022,(3):380.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.027]
[5]张毅堃,陆星瑶,胡鸿毅.寒温统一论视角下的脾胃病证治[J].陕西中医,2024,(10):1382.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.019]
　ZHANG Yikun,LU Xingyao,HU Hongyi.The syndrome differentiation of spleen-stomach disease from perspective of theory of cold and heat syndrome differentiation combination[J].,2024,(6):1382.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.019]

备注/Memo

备注/Memo:
基金项目:中国中医科学院“名医名家传承”项目(CM20141003)
更新日期/Last Update: 2021-06-09